Table of Contents
ISRN Neuroscience
Volume 2013, Article ID 598587, 11 pages
http://dx.doi.org/10.1155/2013/598587
Research Article

Competitive HIF Prolyl Hydroxylase Inhibitors Show Protection against Oxidative Stress by a Mechanism Partially Dependent on Glycolysis

1Department of Neurodegeneration, Lundbeck A/S, Ottiliavej 9, 2500 Valby, Denmark
2Department of Computational and Analytical Chemistry, Lundbeck A/S, Ottiliavej 9, 2500 Valby, Denmark

Received 2 August 2012; Accepted 4 September 2012

Academic Editors: R. Parenti and B.-Y. Zeng

Copyright © 2013 Ann-Louise Bergström et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. G. Kaelin Jr. and P. J. Ratcliffe, “Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway,” Molecular Cell, vol. 30, no. 4, pp. 393–402, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. A. C. R. Epstein, J. M. Gleadle, L. A. McNeill et al., “C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation,” Cell, vol. 107, no. 1, pp. 43–54, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Berra, E. Benizri, A. Ginouvès, V. Volmat, D. Roux, and J. Pouysségur, “HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia,” The EMBO Journal, vol. 22, no. 16, pp. 4082–4090, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Sridharan, J. Guichard, R. M. Bailey, H. Kasiganesan, C. Beeson, and G. L. Wright, “The prolyl hydroxylase oxygen-sensing pathway is cytoprotective and allows maintenance of mitochondrial membrane potential during metabolic inhibition,” American Journal of Physiology—Cell Physiology, vol. 292, no. 2, pp. C719–C728, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Sridharan, J. Guichard, C. Y. Li, R. Muise-Helmericks, C. C. Beeson, and G. L. Wright, “O2-sensing signal cascade: clamping of O2 respiration, reduced ATP utilization, and inducible fumarate respiration,” American Journal of Physiology—Cell Physiology, vol. 295, no. 1, pp. C29–C37, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Thirstrup, S. Christensen, H. A. Møller et al., “Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitors,” Pharmacological Research, vol. 64, no. 3, pp. 268–273, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. J. H. Dao, R. J. M. Kurzeja, J. M. Morachis et al., “Kinetic characterization and identification of a novel inhibitor of hypoxia-inducible factor prolyl hydroxylase 2 using a time-resolved fluorescence resonance energy transfer-based assay technology,” Analytical Biochemistry, vol. 384, no. 2, pp. 213–223, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. H. Rabinowitz et al., “Structure based design and biological evaluation of benzimidazole HIF prolyl hydroxylase inhibitors for the treatment of anemia,” in Proceedings of the 239th ACS National Meeting & Exposition, San Francisco, Calif, USA, March 2010, Abstract MEDI 321.
  9. J. L. Johansen, T. N. Sager, J. Lotharius et al., “HIF prolyl hydroxylase inhibition increases cell viability and potentiates dopamine release in dopaminergic cells,” Journal of Neurochemistry, vol. 115, no. 1, pp. 209–219, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Elstner, C. M. Morris, K. Heim et al., “Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death,” Acta Neuropathologica, vol. 122, no. 1, pp. 75–86, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. D. E. Decker, J. S. Althaus, S. E. Buxser, P. F. VonVoigtlander, and P. L. Ruppel, “Competitive irreversible inhibition of dopamine uptake by 6-hydroxydopamine,” Research Communications in Chemical Pathology and Pharmacology, vol. 79, no. 2, pp. 195–208, 1993. View at Google Scholar · View at Scopus
  12. G. L. Semenza, “Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1,” Biochemical Journal, vol. 405, no. 1, pp. 1–9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. C. M. Tegley, V. N. Viswanadhan, K. Biswas et al., “Discovery of novel hydroxy-thiazoles as HIF-α prolyl hydroxylase inhibitors: SAR, synthesis, and modeling evaluation,” Bioorganic and Medicinal Chemistry Letters, vol. 18, no. 14, pp. 3925–3928, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Ivan, T. Haberberger, D. C. Gervasi et al., “Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 21, pp. 13459–13464, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Nangaku, Y. Izuhara, S. Takizawa et al., “A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 12, pp. 2548–2554, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Milosevic, M. Maisel, F. Wegner et al., “Lack of hypoxia-inducible factor-1α impairs midbrain neural precursor cells involving vascular endothelial growth factor signaling,” Journal of Neuroscience, vol. 27, no. 2, pp. 412–421, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. J. H. Baek, C. E. N. Reiter, D. J. Manalo, P. W. Buehler, R. C. Hider, and A. I. Alayash, “Induction of hypoxia inducible factor (HIF-1α) in rat kidneys by iron chelation with the hydroxypyridinone, CP94,” Biochimica et Biophysica Acta, vol. 1809, no. 4–6, pp. 262–268, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Koivunen, M. Hirsilä, A. M. Remes, I. E. Hassinen, K. I. Kivirikko, and J. Myllyharju, “Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF,” Journal of Biological Chemistry, vol. 282, no. 7, pp. 4524–4532, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. P. E. Hallaway, J. W. Eaton, S. S. Panter, and B. E. Hedlund, “Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 24, pp. 10108–10112, 1989. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Guo, M. Miyake, K. J. Liu, and H. Shi, “Specific inhibition of hypoxia inducible factor 1 exaggerates cell injury induced by in vitro ischemia through deteriorating cellular redox environment,” Journal of Neurochemistry, vol. 108, no. 5, pp. 1309–1321, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Boulahbel, R. V. Durán, and E. Gottlieb, “Prolyl hydroxylases as regulators of cell metabolism,” Biochemical Society Transactions, vol. 37, no. 1, pp. 291–294, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Schlisio, “Neuronal apoptosis by prolyl hydroxylation: Implication in nervous system tumours and the Warburg conundrum,” Journal of Cellular and Molecular Medicine, vol. 13, no. 10, pp. 4104–4112, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. K. V. Tormos and N. S. Chandel, “Inter-connection between mitochondria and HIFs,” Journal of Cellular and Molecular Medicine, vol. 14, no. 4, pp. 795–804, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Wu, X. Li, W. Xie, J. Jankovic, W. Le, and T. Pan, “Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1α and induction of autophagy in SH-SY5Y cells,” Neurochemistry International, vol. 57, no. 3, pp. 198–205, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. W. Tzeng, L. Y. Lee, P. L. Chao, H. C. Lee, R. T. Wu, and A. M. Y. Lin, “Role of autophagy in protection afforded by hypoxic preconditioning against MPP+-induced neurotoxicity in SH-SY5Y cells,” Free Radical Biology and Medicine, vol. 49, no. 5, pp. 839–846, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. K. M. Harms, L. Li, and L. A. Cunningham, “Murine neural stem/progenitor cells protect neurons against ischemia by HIF-1alpha-regulated VEGF signaling,” PloS One, vol. 5, no. 3, p. e9767, 2010. View at Google Scholar · View at Scopus
  27. M. Bergeron, J. M. Gidday, A. Y. Yu, G. L. Semenza, D. M. Ferriero, and F. R. Sharp, “Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain,” Annals of Neurology, vol. 48, no. 3, pp. 285–296, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. D. J. Lomb, J. A. Straub, and R. S. Freeman, “Prolyl hydroxylase inhibitors delay neuronal cell death caused by trophic factor deprivation,” Journal of Neurochemistry, vol. 103, no. 5, pp. 1897–1906, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. D. W. Lee, S. Rajagopalan, A. Siddiq et al., “Inhibition of prolyl hydroxylase protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. Model for the potential involvement of the hypoxia-unducible factor pathway in Parkinson disease,” Journal of Biological Chemistry, vol. 284, no. 42, pp. 29065–29076, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. N. S. Zur, B. Tomaselli, and G. Baier-Bitterlich, “HIF-1 alpha is an essential effector for purine nucleoside-mediated neuroprotection against hypoxia in PC12 cells and primary cerebellar granule neurons,” Journal of Neurochemistry, vol. 105, no. 5, pp. 1901–1914, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. B. López-Hernández, I. Posadas, P. Podlesniy, M. A. Abad, R. Trullas, and V. Ceña, “HIF-1α is neuroprotective during the early phases of mild hypoxia in rat cortical neurons,” Experimental Neurology, vol. 233, no. 1, pp. 543–544, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Vazquez-Valls, M. E. Flores-Soto, V. Chaparro-Huerta et al., “HIF-1α expression in the hippocampus and peripheral macrophages after glutamate-induced excitotoxicity,” Journal of Neuroimmunology, vol. 228, no. 1, pp. 12–18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Ara, S. Fekete, M. Frank, J. A. Golden, D. Pleasure, and I. Valencia, “Hypoxic-preconditioning induces neuroprotection against hypoxia-ischemia in newborn piglet brain,” Neurobiology of Disease, vol. 43, no. 2, pp. 473–485, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. I. Lushnikova, M. Orlovsky, V. Dosenko, A. Maistrenko, and G. Skibo, “Brief anoxia preconditioning and HIF prolyl-hydroxylase inhibition enhances neuronal resistance in organotypic hippocampal slices on model of ischemic damage,” Brain Research, vol. 1386, pp. 175–183, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. X. W. Liu, Y. Su, H. Zhu et al., “HIF-1α-dependent autophagy protects HeLa cells from fenretinide (4-HPR)-induced apoptosis in hypoxia,” Pharmacological Research, vol. 62, no. 5, pp. 416–425, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Loor and P. T. Schumacker, “Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion,” Cell Death and Differentiation, vol. 15, no. 4, pp. 686–690, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. K. U. Eckardt, W. M. Bernhardt, A. Weidemann et al., “Role of hypoxia in the pathogenesis of renal disease,” Kidney International, vol. 68, no. 99, pp. S46–S51, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Witten, T. Sager, K. Thirstrup et al., “HIF prolyl hydroxylase inhibition augments dopamine release in the rat brain in vivo,” Journal of Neuroscience Research, vol. 87, no. 7, pp. 1686–1694, 2009. View at Publisher · View at Google Scholar · View at Scopus